Literature DB >> 11113458

Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface.

M Yamamoto1, H Hara, T Adachi.   

Abstract

Homocysteine is known to be a risk factor for several vascular diseases. Previously, we found a significant association between plasma homocysteine and plasma extracellular-superoxide dismutase (EC-SOD) levels. The binding of EC-SOD to human and bovine aortic endothelial cell cultures showed significant decreases after incubation with 10 microM homocysteine, whereas the expression of EC-SOD in fibroblast cell cultures was inhibited with a high concentration (1 mM) of homocysteine. Furthermore, binding of EC-SOD to heparin immobilized on plates was decreased with homocysteine. These observations suggested that homocysteine decreases the binding of EC-SOD to vascular endothelial cell surfaces by degradation of endothelial heparan sulfate proteoglycan, which results in a loss of the ability to protect endothelial cell surfaces from oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113458     DOI: 10.1016/s0014-5793(00)02260-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Homocysteine alters glutamate uptake and Na+,K+-ATPase activity and oxidative status in rats hippocampus: protection by vitamin C.

Authors:  Fernanda R Machado; Andréa G K Ferreira; Aline A da Cunha; Bárbara Tagliari; Ben Hur M Mussulini; Susana Wofchuk; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2011-02-03       Impact factor: 3.584

Review 2.  Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.

Authors:  Dorothea Rosenberger; Karni S Moshal; Ganesh K Kartha; Neetu Tyagi; Utpal Sen; David Lominadze; Claudio Maldonado; Andrew M Roberts; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2006 Oct-Dec       Impact factor: 4.076

3.  Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.

Authors:  Neetu Tyagi; Natia Qipshidze; Utpal Sen; Walter Rodriguez; Alexander Ovechkin; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-08

4.  The Roles of Two miRNAs in Regulating the Immune Response of Sea Cucumber.

Authors:  Pengjuan Zhang; Chenghua Li; Ran Zhang; Weiwei Zhang; Chunhua Jin; Lingling Wang; Linsheng Song
Journal:  Genetics       Date:  2015-10-19       Impact factor: 4.562

5.  Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.

Authors:  Srikanth Givvimani; Natia Qipshidze; Neetu Tyagi; Paras K Mishra; Utpal Sen; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-05-29

6.  Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function.

Authors:  David E L Wilcken; Jun Wang; Ah Siew Sim; Kathryn Green; Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

Review 7.  Superoxide dismutases: role in redox signaling, vascular function, and diseases.

Authors:  Tohru Fukai; Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2011-06-06       Impact factor: 8.401

8.  Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide.

Authors:  Connie W H Woo; Filly Cheung; Vincent W H Chan; Yaw L Siow; Karmin O
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

Review 9.  Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD.

Authors:  Zhenyu Qin; Krzysztof J Reszka; Tohru Fukai; Neal L Weintraub
Journal:  Transl Res       Date:  2007-11-08       Impact factor: 7.012

10.  Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients.

Authors:  Hiroshi Izuta; Yuichi Chikaraishi; Tetsuo Adachi; Masamitsu Shimazawa; Tetsuya Sugiyama; Tsunehiko Ikeda; Hideaki Hara
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.